Importance of serum phosphate in elderly patients with diabetes mellitus

doi:10.4239/wjd.v11.i10.416

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7122)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-4) series.

Item

Count

PDF

425

HTML

3601

Tables (1-4)

583

Sum=4609

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

840

Download

1668

Sum=2508

Oct 15, 2020 (publication date) through Dec 12, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Case Control Study

World J Diabetes. Oct 15, 2020; 11(10): 416-424
Published online Oct 15, 2020. doi: 10.4239/wjd.v11.i10.416

Table 1 The differences between groups of patients according to serum phosphate higher or lower than the cut-off point related to diabetes mellitus equal to 3.65 mg/dL

Characteristic	Patients with serum P > 3.65 mg/dL (n = 43), mean ± SD	Patients with serum P < 3.65 mg/dL (n = 67), mean ± SD	P value
Age (yr)	71.2 ± 12.8	67.6 ± 15.2	0.2
BMI (kg/m²)	30.2 ± 6.3^a	28.1 ± 4.6	0.04
WC (cm)	108.09 ± 15.9	102.8 ± 14.3	0.07
Uric acid (mg/dL)	6.7 ± 1.2^a	6.09 ± 1.7	0.05
LDL-C (mg/dL)	102.2 ± 29.5	110.1 ± 32.1	0.2
HDL-C (mg/dL)	44.5 ± 13.2	47.1 ± 9.8	0.2
Triglycerides (mg/dL)	137.7 ± 54.4	129.01 ± 60.1	0.4
Calcium (mg/dL)	9.5 ± 0.6	9.5 ± 0.5	0.9
P (mg/dL)	4.2 ± 0.4^a	3.2 ± 0.3	0.001
i-PTH (pg/mL)	mean rank = 68.06^a	47.4	0.001
25(OH)D3 (ng/mL)	18.9 ± 12.7	20.8 ± 9.2	0.3
Glucose (mg/dL)	mean rank = 63.6^a	50.28	0.03
Insulin (μU/mL)	11.6 ± 7.4	11.9 ± 8.7	0.8
HOMA-IR (mmol/L)	mean rank = 56.8	54.6	0.7
SBP (mmHg)	147.4 ± 16.7^a	140.2 ± 16.1	0.02
DBP (mmHg)	mean rank = 62.08	51.28	0.07
pMBP (mmHg)	108.02 ± 9.8^a	103.6 ± 7.8	0.01
PP (mmHg)	65.7 ± 16.2	61.01 ± 17.7	0.1
ACR (mg/g)	mean rank = 63.2^a	50.6	0.04
eGFR (mL/min/1.73 m²)	45.6 ± 22.1^a	55.4 ± 21.5	0.02
Category variables	n (%)	n (%)
DM (yes/no)	17 (39.5)/26 (60.5)^a	12 (17.9)/55 (82.1)	0.01
Hypertension (yes/no)	34 (79.1)/9 (20.9)^a	41 (61.2)/26 (38.8)	0.03
Receiving vitD (yes/no)	22 (51.2)/21 (48.8)^a	18 (26.9)/49 (73.1)	0.009
Smoking (yes/no)	10 (23.3)/33 (76.7)^a	4 (6)/63 (94)	0.01
Alcohol consumption (yes/no)	13 (30.2)/30 (69.8)	16 (23.9)/51 (76.1)	0.3
Physical activity (yes/no)	17 (39.5)/26 (60.5)	34 (50.7)/33 (49.3)	0.1
Classification based on eGFR:			0.04
eGFR > 90 mL/min/1.73 m²	3 (7)^a	6 (9)
eGFR = 60-90 mL/min/1.73 m²	7 (16.3)	18 (26.9)
eGFR = 30-60 mL/min/1.73 m²	21 (48.8)	37 (55.2)
eGFR = 15-30 mL/min/1.73 m²	12 (27.9)	6 (9)

^aP < 0.05. P: Phosphate; BMI: Body mass index; WC: Waist circumference; LDL-C: Low density lipoprotein cholesterol; HDL-C: High density lipoprotein cholesterol; i-PTH: Intact-parathyroid hormone; 25(OH)D₃: 25 hydroxyD₃; HOMA-IR: Homeostasis model assessment of insulin resistance; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; pMBP: Peripheral mean blood pressure; PP: Pulse pressure; ACR: Albumin-to-creatinine ratio; eGFR: Estimated glomerular filtration rate; DM: Diabetes mellitus.

Full Size Table

Table 2 Logistic regression analysis for predicting diabetes mellitus manifestations

Variables in model	P value	Odds ratio	Confidence interval
Age (yr)	0.003	1.07	1.02-1.13
Gender (male/female)	0.04	0.30	0.09–0.99
BMI (kg/m²)	0.02	1.11	1.01–1.22
Hypertension (yes/no)	0.4	1.58	0.4–5.9
Smoking (yes/no)	0.08	3.7	0.8–17.02
Calcium (mg/dL)	0.2	1.6	0.7–3.7
P (mg/dL)	0.9	1.05	0.4–2.4

DM: Diabetes mellitus; BMI: Body mass index; P: Phosphate.

Full Size Table

Table 3 Relation to serum glucose variables in our participants without diabetes mellitus (n = 81)

Variables in model	Beta	t	Sig.	Lower	Upper
Age (yr)	-0.02	-0.17	0.8	-0.28	0.24
Gender (male/female)	-0.03	-0.3	0.7	-7.8	5.6
BMI (kg/m²)	0.4	3.9	0.001	0.5	1.6
Hypertension (yes/no)	0.02	0.2	0.8	-6.5	8.2
Smoking (yes/no)	0.04	0.3	0.7	-8.4	12.09
eGFR value (mL/min/1.73 m²)	- 0.2	- 1.6	0.1	-0.3	0.03
ACR (mg/g)	0.03	0.2	0.7	-0.007	0.01
Calcium (mg/dL)	0.13	1.2	0.2	-2.4	9.7
P (mg/dL)	0.1	0.9	0.3	-2.7	7.7

Dependent variable: serum glucose. DM: Diabetes mellitus; BMI: Body mass index; eGFR: Estimated glomerular filtration rate; ACR: Albumin-to-creatinine ratio; P: Phosphate.

Full Size Table

Table 4 Relation to serum glucose variables in our patients with diabetes mellitus (n = 29)

Variables in model	Beta	t	Sig.	Lower	Upper
Age (yr)	0.26	1.02	0.3	-1.06	3.1
Gender (male/female)	0.06	0.2	0.7	-30.5	39.8
BMI (kg/m²)	0.3	1.2	0.2	-1.6	6.5
Hypertension (yes/no)	-0.2	-1.3	0.19	-70.04	15.5
Smoking (yes/no)	0.33	1.4	0.15	-12.7	74.4
eGFR value (mL/min/1.73 m²)	- 0.06	-0.2	0.79	-1.1	0.86
ACR (mg/g)	0.4	2.2	0.03	0.003	0.09
Calcium (mg/dL)	0.2	1.1	0.2	-10.6	38.2
P (mg/dL)	-0.13	-0.6	0.5	-32.4	17.07

Dependent variable: serum glucose. DM: Diabetes mellitus; BMI: Body mass index; eGFR: Estimated glomerular filtration rate; ACR: Albumin-to-creatinine ratio; P: Phosphate.

Full Size Table

Citation: Raikou VD, Kyriaki D, Gavriil S. Importance of serum phosphate in elderly patients with diabetes mellitus. World J Diabetes 2020; 11(10): 416-424
URL: https://www.wjgnet.com/1948-9358/full/v11/i10/416.htm
DOI: https://dx.doi.org/10.4239/wjd.v11.i10.416